InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the complete record of transactions filed by Moore Paul Andrew. Director active across 1 company, notably Zymeworks Inc.. In total, 4 filings have been published. Activity tracked since 5 January 2024. The latest transaction was disclosed on 12 January 2026 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations
Moore Paul Andrew has 4 filings in total, all on Zymeworks Inc., and the recent sampled filings cover the period from 2024-01-08 to 2026-01-12. His listed role is Chief Scientific Officer, and the modal transaction nature is Levée d'options, with buy and sell amounts of EUR 0 in this sample.